Abstract

Angelman Syndrome (AS) is a rare neurodevelopmental disorder caused by loss of function of the maternally inherited copy of UBE3A, an imprinted gene expressed biallelically in most tissues, but expressed exclusively from the maternal allele in neurons. Active transcription of the neuron-specific long non-coding RNA (lncRNA), UBE3A-ATS, has been shown to silence paternal UBE3A. We hypothesized that alternative splicing factors RBFOX2 and RBFOX1 might mediate splicing changes and result in the transcription of UBE3A-ATS in neurons. We found that RBFOX2 and RBFOX1 both bind to UBE3A-ATS transcript in neurons, but are not required for gene expression and/or neuron-specific processing in the SNURF/SNRPN-UBE3A region. However, we found that depletion of RBFOX2 causes a proliferation phenotype in immature neural cultures, suggesting that RBFOX2 is involved in division versus differentiation decisions in iPSC-derived neural progenitors. Absence of RBFOX2 also altered the expression of some genes that are important for glutamatergic neocortical development and Wnt-Frizzled signalling in mature neuronal cultures. Our data show that while RBFOX1 and RBFOX2 do not mediate neuron-specific processing of UBE3A-ATS, these proteins play important roles in developing neurons and are not completely functionally redundant.

Highlights

  • Angelman syndrome (AS), a neurodevelopmental disorder affecting approximately 1/15,000–1/30,000 live births[1], is characterized by microcephaly, seizures, ataxia, lack of speech, happy demeanor, and severe cognitive disability[2]

  • Previous studies indicated that RBFOX2 and its protein product are expressed in a broad spectrum of tissues and cell types, including hESCs9,11, while RBFOX1 and its protein product are expressed in brain and muscle cells[11]

  • Yeo et al showed abundant RBFOX2-binding on the SNURF/SNRPN long non-coding RNA (lncRNA) in hESCs9

Read more

Summary

Introduction

Angelman syndrome (AS), a neurodevelopmental disorder affecting approximately 1/15,000–1/30,000 live births[1], is characterized by microcephaly, seizures, ataxia, lack of speech, happy demeanor, and severe cognitive disability[2]. In addition to the protein-coding SNURF and SNRPN transcripts, this gene produces several members of the SNORD116 and SNORD115 snoRNA clusters, as well as lncRNAs of unknown function, such as IMPRINTED IN PRADER-WILLI (IPW) and UBE3A-ATS5. The lncRNAs between SNURF/SNRPN protein-coding portion and the IPW lncRNA are expressed broadly in many tissue types, but the lncRNA downstream of IPW, including the SNORD115 cluster and UBE3A-ATS are neuron-specific[4]. It is important to understand the regulation of the neuron-specific portion of SNURF/SNRPN lncRNA, since it, in turn, controls UBE3A imprinted expression[7,8]. A previous crosslinking-immunoprecipitation-sequencing (CLIP-Seq) study in human embryonic stem cells (hESCs) showed that the SNURF/SNRPN lncRNA is highly bound by an alternative splicing factor, RBFOX2. We found a neural differentiation defect in RBFOX2-null iPSCs, suggesting that RBFOX2 is involved in division versus differentiation decisions in iPSC-derived neural progenitors

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call